Simultaneous determination of mycotoxins in biological fluids by LC-MS/MS

Alberto Ritieni, Antonello Santini, Michele Mussap, Rosalia Ferracane, Paolo Bosco, Diego Gazzolo, Fabio Galvano

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

We report a single, reliable, non-invasive analytical method for monitoring the fetal level of exposure to different mycotoxins. We assessed by tandem mass spectrometry levels up to 200 nanog/l for ochratoxin A and 500 nanog/l for aflatoxins in sample of serum (n= 71), urine (n= 18) and amniotic fluid (n= 21) of pregnant women. Aflatoxin G1 was present in one sample of serum (3.48 microg/l) and in four samples of urine (ranging from 14.0 to 18.8 microg/l), ochratoxin A was present in one sample of amniotic fluid (4.26 microg/l), whereas aflatoxin B1 (ranging from 0.4-2 microg/l) and B2 (ranging from 0.3-3 microg/l) were contextually present in two samples of urine. The very few contaminated samples did not allow statistical comparison between subjects grouped according to the frequency of consumption of commonly contaminated foods. Data confirm that mycotoxins can occur in fetal-maternal biological fluids. However, the incidence and the level of exposure to the investigated mycotoxins do not appear to pose risk for the mother and the fetus.

Original languageEnglish
Pages (from-to)151-158
Number of pages8
JournalFrontiers in Bioscience - Elite
Volume2 E
Issue number1
Publication statusPublished - Jan 1 2010

Fingerprint

Mycotoxins
Urine
Amniotic Fluid
Fluids
Mothers
Fetal Monitoring
Aflatoxin B1
Aflatoxins
Tandem Mass Spectrometry
Serum
Mass spectrometry
Pregnant Women
Fetus
Food
Monitoring
Incidence
ochratoxin A

Keywords

  • Aflatoxins
  • Biological fluids
  • LCMS/MS
  • Ochratoxin A
  • OTA

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Medicine(all)

Cite this

Ritieni, A., Santini, A., Mussap, M., Ferracane, R., Bosco, P., Gazzolo, D., & Galvano, F. (2010). Simultaneous determination of mycotoxins in biological fluids by LC-MS/MS. Frontiers in Bioscience - Elite, 2 E(1), 151-158.

Simultaneous determination of mycotoxins in biological fluids by LC-MS/MS. / Ritieni, Alberto; Santini, Antonello; Mussap, Michele; Ferracane, Rosalia; Bosco, Paolo; Gazzolo, Diego; Galvano, Fabio.

In: Frontiers in Bioscience - Elite, Vol. 2 E, No. 1, 01.01.2010, p. 151-158.

Research output: Contribution to journalArticle

Ritieni, A, Santini, A, Mussap, M, Ferracane, R, Bosco, P, Gazzolo, D & Galvano, F 2010, 'Simultaneous determination of mycotoxins in biological fluids by LC-MS/MS', Frontiers in Bioscience - Elite, vol. 2 E, no. 1, pp. 151-158.
Ritieni A, Santini A, Mussap M, Ferracane R, Bosco P, Gazzolo D et al. Simultaneous determination of mycotoxins in biological fluids by LC-MS/MS. Frontiers in Bioscience - Elite. 2010 Jan 1;2 E(1):151-158.
Ritieni, Alberto ; Santini, Antonello ; Mussap, Michele ; Ferracane, Rosalia ; Bosco, Paolo ; Gazzolo, Diego ; Galvano, Fabio. / Simultaneous determination of mycotoxins in biological fluids by LC-MS/MS. In: Frontiers in Bioscience - Elite. 2010 ; Vol. 2 E, No. 1. pp. 151-158.
@article{d36e5be378ab436b9847492e8562c166,
title = "Simultaneous determination of mycotoxins in biological fluids by LC-MS/MS",
abstract = "We report a single, reliable, non-invasive analytical method for monitoring the fetal level of exposure to different mycotoxins. We assessed by tandem mass spectrometry levels up to 200 nanog/l for ochratoxin A and 500 nanog/l for aflatoxins in sample of serum (n= 71), urine (n= 18) and amniotic fluid (n= 21) of pregnant women. Aflatoxin G1 was present in one sample of serum (3.48 microg/l) and in four samples of urine (ranging from 14.0 to 18.8 microg/l), ochratoxin A was present in one sample of amniotic fluid (4.26 microg/l), whereas aflatoxin B1 (ranging from 0.4-2 microg/l) and B2 (ranging from 0.3-3 microg/l) were contextually present in two samples of urine. The very few contaminated samples did not allow statistical comparison between subjects grouped according to the frequency of consumption of commonly contaminated foods. Data confirm that mycotoxins can occur in fetal-maternal biological fluids. However, the incidence and the level of exposure to the investigated mycotoxins do not appear to pose risk for the mother and the fetus.",
keywords = "Aflatoxins, Biological fluids, LCMS/MS, Ochratoxin A, OTA",
author = "Alberto Ritieni and Antonello Santini and Michele Mussap and Rosalia Ferracane and Paolo Bosco and Diego Gazzolo and Fabio Galvano",
year = "2010",
month = "1",
day = "1",
language = "English",
volume = "2 E",
pages = "151--158",
journal = "Frontiers in Bioscience - Elite",
issn = "1945-0494",
publisher = "Frontiers in Bioscience",
number = "1",

}

TY - JOUR

T1 - Simultaneous determination of mycotoxins in biological fluids by LC-MS/MS

AU - Ritieni, Alberto

AU - Santini, Antonello

AU - Mussap, Michele

AU - Ferracane, Rosalia

AU - Bosco, Paolo

AU - Gazzolo, Diego

AU - Galvano, Fabio

PY - 2010/1/1

Y1 - 2010/1/1

N2 - We report a single, reliable, non-invasive analytical method for monitoring the fetal level of exposure to different mycotoxins. We assessed by tandem mass spectrometry levels up to 200 nanog/l for ochratoxin A and 500 nanog/l for aflatoxins in sample of serum (n= 71), urine (n= 18) and amniotic fluid (n= 21) of pregnant women. Aflatoxin G1 was present in one sample of serum (3.48 microg/l) and in four samples of urine (ranging from 14.0 to 18.8 microg/l), ochratoxin A was present in one sample of amniotic fluid (4.26 microg/l), whereas aflatoxin B1 (ranging from 0.4-2 microg/l) and B2 (ranging from 0.3-3 microg/l) were contextually present in two samples of urine. The very few contaminated samples did not allow statistical comparison between subjects grouped according to the frequency of consumption of commonly contaminated foods. Data confirm that mycotoxins can occur in fetal-maternal biological fluids. However, the incidence and the level of exposure to the investigated mycotoxins do not appear to pose risk for the mother and the fetus.

AB - We report a single, reliable, non-invasive analytical method for monitoring the fetal level of exposure to different mycotoxins. We assessed by tandem mass spectrometry levels up to 200 nanog/l for ochratoxin A and 500 nanog/l for aflatoxins in sample of serum (n= 71), urine (n= 18) and amniotic fluid (n= 21) of pregnant women. Aflatoxin G1 was present in one sample of serum (3.48 microg/l) and in four samples of urine (ranging from 14.0 to 18.8 microg/l), ochratoxin A was present in one sample of amniotic fluid (4.26 microg/l), whereas aflatoxin B1 (ranging from 0.4-2 microg/l) and B2 (ranging from 0.3-3 microg/l) were contextually present in two samples of urine. The very few contaminated samples did not allow statistical comparison between subjects grouped according to the frequency of consumption of commonly contaminated foods. Data confirm that mycotoxins can occur in fetal-maternal biological fluids. However, the incidence and the level of exposure to the investigated mycotoxins do not appear to pose risk for the mother and the fetus.

KW - Aflatoxins

KW - Biological fluids

KW - LCMS/MS

KW - Ochratoxin A

KW - OTA

UR - http://www.scopus.com/inward/record.url?scp=77954500615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954500615&partnerID=8YFLogxK

M3 - Article

C2 - 20036865

AN - SCOPUS:77954500615

VL - 2 E

SP - 151

EP - 158

JO - Frontiers in Bioscience - Elite

JF - Frontiers in Bioscience - Elite

SN - 1945-0494

IS - 1

ER -